Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Flu Vaccine Licensure Depends On Adjuvant; Fall Vaccination Campaign Likely

Executive Summary

Efforts are under way to expedite H1N1 vaccine development for a potential voluntary vaccine campaign in the fall, but how registration of the vaccine is handled by FDA depends on whether or not an adjuvant is used

You may also be interested in...



BioCryst Stock Rises After White House Calls For Quicker Pace On Swine Flu Drugs

Two Phase III trials are planned for a flu antiviral this year, but the company could be asked to provide supplies for U.S. emergency stockpile before approval.

Two-Dose H1N1 Vaccination Might Be Optimal, But Would Stress Supply

An FDA panel said the H1N1 flu vaccine should be given in two doses when the probable vaccine campaign starts in the fall, but government officials at the meeting said there will not likely be enough vaccine available at that point to follow that advice

Two-Dose H1N1 Vaccination Might Be Optimal, But Would Stress Supply

An FDA panel said the H1N1 flu vaccine should be given in two doses when the probable vaccine campaign starts in the fall, but government officials at the meeting said there will not likely be enough vaccine available at that point to follow that advice

Related Content

Topics

UsernamePublicRestriction

Register

MT142578

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel